GEOGRAPHIC ATROPHY
Clinical trials for GEOGRAPHIC ATROPHY explained in plain language.
Never miss a new study
Get alerted when new GEOGRAPHIC ATROPHY trials appear
Sign up with your email to follow new studies for GEOGRAPHIC ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy trial for dry AMD shows early promise but study halted
Disease control TerminatedThis study tested a single injection of a gene therapy called GT005 in 56 people with dry age-related macular degeneration (AMD), a leading cause of vision loss. The goal was to see if it was safe and could slow or stop damage to the retina. The trial was stopped early, so result…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE1, PHASE2 • Sponsor: Gyroscope Therapeutics Limited • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
Eye drug trial halted: danicopan fails to slow vision loss in macular degeneration
Disease control TerminatedThis study tested a drug called danicopan in 365 people with geographic atrophy, a form of advanced age-related macular degeneration that causes blind spots. The goal was to see if danicopan could slow the growth of these blind spots over two years. The trial was stopped early, a…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 18, 2026 12:02 UTC